HPV and Other Risk Factors for Cervical Cancer in Greenland and Denmark
Author Information
Author(s): S.K. Kjaerl, E.-M. de Villiers, H. Qaglayan, E. Svare, B.J. Haugaard, G. Engholm, R. B. Christensen, K.A. M0ller, P. Poll, H. Jensen, B.F. Vestergaard, E. Lyngel, O.M. Jensen
Primary Institution: Danish Cancer Registry, Institute of Cancer Epidemiology, Danish Cancer Society
Hypothesis
Is there a difference in the prevalence of HPV infection and other risk factors for cervical cancer between high-risk (Greenland) and low-risk (Denmark) areas?
Conclusion
The study found no significant difference in HPV detection rates between Greenland and Denmark, despite higher cervical cancer incidence in Greenland.
Supporting Evidence
- HPV detection rates were similar in both regions using ViraPap.
- Significantly more Greenlandic women had antibodies to HSV-2 compared to Danish women.
- Greenlandic women reported more sexual partners and earlier sexual debut than Danish women.
- The prevalence of self-reported histories of selected venereal diseases was higher among Greenlanders.
Takeaway
The study looked at women in Greenland and Denmark to see if HPV infection is linked to cervical cancer. They found that even though more women in Greenland had HPV, it didn't explain why they had more cervical cancer.
Methodology
A population-based cross-sectional study was conducted with random samples of women aged 20-39 from both regions, using interviews and biological samples for HPV and HSV testing.
Potential Biases
Potential misclassification of HPV infection could influence results.
Limitations
The study only measured HPV at one point in time, which may not reflect the risk of cervical cancer accurately.
Participant Demographics
Women aged 20-39, with 129 from Greenland and 126 from Denmark.
Statistical Information
P-Value
0.36
Confidence Interval
95% CI 0.8-2.1
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website